A review of selected Federal vaccine and immunization policies : based on case studies of pneumococcal vaccine.

Front Cover
DIANE Publishing
 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

III
3
IV
4
V
7
VI
10
VIII
11
IX
12
X
13
XI
16
XLV
89
XLVI
92
XLVII
93
XLVIII
95
XLIX
97
LI
98
LII
99
LIII
103

XII
17
XIII
23
XIV
32
XV
33
XVI
34
XVII
36
XVIII
41
XIX
43
XX
47
XXI
49
XXII
51
XXIII
52
XXIV
56
XXV
57
XXVI
60
XXVII
64
XXIX
66
XXX
67
XXXI
68
XXXIII
69
XXXIV
70
XXXV
71
XXXVI
72
XXXVII
73
XXXVIII
76
XXXIX
77
XL
78
XLI
83
XLII
87
XLIV
88
LIV
107
LV
109
LVII
112
LVIII
115
LIX
119
LX
125
LXI
130
LXII
134
LXIV
135
LXV
137
LXVI
139
LXVII
144
LXVIII
149
LXIX
150
LXX
155
LXXII
157
LXXIII
158
LXXIV
159
LXXV
163
LXXVI
164
LXXVII
166
LXXVIII
169
LXXIX
175
LXXX
182
LXXXI
184
LXXXII
187
LXXXIII
194
LXXXV
196
Copyright

Common terms and phrases

Popular passages

Page xiii - Efficacy: The probability of benefit to individuals in a defined population from a medical technology applied for a given medical problem under ideal conditions of use.
Page 180 - ... to 9,000 Medicare beneficiaries with organ transplants will approach $35 million in 1987, or about $4,000 per beneficiary. Immunizations are covered only in specific circumstances: vaccination against pneumococcal pneumonia and hepatitis B (for those at medium or high risk only) and immunization directly related to the treatment of an injury or direct exposure to a disease or condition such as rabies or tetanus. Most immunizations, such as for smallpox and influenza, are not covered. Medicare...
Page 26 - T_ a s. [Page Omitted] This page was originally printed on a gray background. The scanned version of the page is almost entirely black and is unusable. It has been intentionally omitted. If a replacement page image of higher quality becomes available, it will be posted within the copy of this report found on one of the OTA websites.
Page xiv - Medical technology: The drugs, devices, and medical and surgical procedures used in medical care, and the organizational and supportive systems within which such care is provided.
Page vi - University Robert M. Ball Senior Scholar Institute of Medicine National Academy of Sciences Lewis H.
Page 92 - ... ...Statistically predictable as are these rare cases of vaccine-induced polio, a strong argument can be advanced that the loss ought not lie where it falls (on the victim), but should be borne by the manufacturer as a foreseeable cost of doing business, and passed on to the public in the form of price increases to his customers.
Page 64 - And program budgeting at the highest levels leaves pure efficiency far behind its overreaching grasp into the structure of the political system. Program budgeting, it turns out, is a form of systems analysis, that is, political systems analysis. These modes of analysis are neither good for nothing nor good for everything, and one cannot speak of them as wholly good or bad. It is much more useful to try to specify some conditions under which they would or would not be helpful for various purposes....
Page vii - Hospital of San Francisco John D. Chase Associate Dean for Clinical Affairs University of Washington School of Medicine Joseph Fletcher Visiting Scholar Medical Ethics School of Medicine University of Virginia Clark C. Havighurst Professor of Law School of Law Duke University Sheldon Leonard...
Page 164 - ... experiences that may influence a determination as to the effectiveness of combinations of the individual active components. 5. Pertinent medical and scientific literature. C. Finished biological product. 1. Controlled studies. 2. Partially controlled or uncontrolled studies. 3. Documented case reports. 4. Pertinent marketing experiences that may influence a determination as to the effectiveness of the finished biological product.
Page 199 - Pneumococcal Bacteremia with Especial Reference to Bacteremic Pneumococcal Pneumonia.

Bibliographic information